Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             27 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Advances in tuberculosis control during the past decade Naidoo, Kogieleum

11 4 p. 311-313
artikel
2 Clinical case definition of post-COVID-19 condition in children: a good start, but improvements are needed Burki, Talha

11 4 p. 314
artikel
3 Clinical trials of tuberculosis vaccines in the era of increased access to preventive antibiotic treatment Rangaka, Molebogeng X

11 4 p. 380-390
artikel
4 Concerns regarding a suggested long COVID paradigm Schwendinger, Fabian

11 4 p. e33
artikel
5 Concerns regarding a suggested long COVID paradigm van der Palen, Jenny

11 4 p. e34
artikel
6 Concerns regarding a suggested long COVID paradigm Cornish, Flora

11 4 p. e35
artikel
7 Concerns regarding a suggested long COVID paradigm – Authors' reply Saunders, Chloe

11 4 p. e36-e37
artikel
8 Continuation of enteral nutrition until extubation in critically ill patients Lobmeyr, Elisabeth

11 4 p. 298-299
artikel
9 Continued enteral nutrition until extubation compared with fasting before extubation in patients in the intensive care unit: an open-label, cluster-randomised, parallel-group, non-inferiority trial Landais, Mickaël

11 4 p. 319-328
artikel
10 Correction to Lancet Respir Med 2023; published online Feb 3. https://doi.org/10.1016/S2213-2600(22)00491-X
11 4 p. e38
artikel
11 Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Mayer-Hamblett, Nicole

11 4 p. 329-340
artikel
12 Do chest x-ray-positive, sputum-negative individuals warrant more attention during tuberculosis screening? Kendall, Emily A

11 4 p. 304-306
artikel
13 Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study Solomon, Benjamin J

11 4 p. 354-366
artikel
14 First-line lorlatinib for advanced ALK-positive non-small-cell lung cancer Lin, Jessica J

11 4 p. 302-304
artikel
15 Kogie Naidoo—when one condition leads to another Kirby, Tony

11 4 p. 315
artikel
16 Philip Morris ejected from Canadian vaccine collaboration Kirby, Tony

11 4 p. e40
artikel
17 Respiratory syncytial virus-induced disease in healthy infants: we need to offload this burden Bem, Reinout A

11 4 p. 301-302
artikel
18 Sedative medications: an avoidable cause of asthma and COPD exacerbations? Chalitsios, Christos V

11 4 p. e31-e32
artikel
19 SIMPLIFYing cystic fibrosis treatment in a post-modulator era Yang, Connie

11 4 p. 299-300
artikel
20 Stalking the Great Killer: Arkansas's Long War on Tuberculosis Burki, Talha

11 4 p. 316
artikel
21 Surviving sepsis with multiple serious complications Kirby, Tony

11 4 p. 317-318
artikel
22 The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study Wildenbeest, Joanne G

11 4 p. 341-353
artikel
23 The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis Sossen, Bianca

11 4 p. 367-379
artikel
24 Time to invest in tuberculosis research and disease control The Lancet Respiratory Medicine,

11 4 p. 297
artikel
25 Tuberculosis and nutrition: what gets measured gets managed McQuaid, C Finn

11 4 p. 308-310
artikel
26 US researchers call for FDA action to avoid another EVALI outbreak Furlow, Bryant

11 4 p. e39
artikel
27 Vaccine anaphylaxis and Canadian public health policy Abrams, Elissa M

11 4 p. 306-308
artikel
                             27 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland
Toegankelijkheidsverklaring